🇮🇳IN
Sign In
MO

MOLBIO

NSE

Molbio Diagnostics Ltd

₹1,239.10

-20.60(-1.64%)
FSI

Fundamental Strength Index

computed from the statements below↑ higher is better

Weights come from configuration, not from this page — each pillar links to the section below that explains it.

Income stmtHistory

Profitability

headline ratios

Growth

compounded, from filed annual results

Segment Results

₹ Cr

Working Capital & Efficiency

days · ROCE %

MOLBIO financial summary

For Mar 2026, Molbio Diagnostics Ltd reported revenue of ₹1,313 crore, which grew 35.2% from the previous year. Net profit was ₹145 crore, which grew 3.6% year on year, on an operating margin of 19%. Earnings per share came in at ₹12.83. Annual results are available for 6 financial years, from Mar 2021 to Mar 2026.

Revenue₹1,313 crore
Net profit₹145 crore
Operating margin19%
EPS₹12.83

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer